TY - JOUR
T1 - Molecular characterization of angiotensin II type II receptors in rat pheochromocytoma cells
AU - Webb, Maria L.
AU - Liu, Eddie C.K.
AU - Cohen, Robert B.
AU - Hedberg, Anders
AU - Bogosian, Elizabeth A.
AU - Monshizadegan, Hossain
AU - Molloy, Chris
AU - Serafino, Randy
AU - Moreland, Suzanne
AU - Murphy, T. J.
AU - Dickinson, Kenneth E.J.
PY - 1992
Y1 - 1992
N2 - The binding sites and biochemical effects of angiotensin (A) II were investigated in rat pheochromocytoma (PC12W) cells. Sarcosine1, [125I]-tyrosine4, isoleucine8-AII ([125I]-SI-AII) bound to a saturable population of sites on membranes with an equilibrium dissociation constant (Kd) of 0.4 nM and a binding site maximum of 254 fmol/mg protein. Competitive displacement of [125I]-SI-AII by agonists and antagonists elucidated a rank order of potency of AIII ≥ AII > PD 123177 > AI > [des-Phe]AII [AII(1-7)] ≫ DuP 753. The stable guanine nucleotide analog 5′-guanylyl imidodiphosphate did not alter the binding affinity or slope of the inhibition curves for AI, AII, AIII, or AII(1-7). Treatment of PC12W cells with AII or AIII did not affect the free intracellular calcium concentration, phosphoinositide metabolism, arachidonate release, cyclic GMP, or cyclic AMP concentrations. [125I]-AII binding sites remained on the cell surface and were not internalized after 2 h at 37°C. Angiotensin II did not stimulate tyrosine, serine, or threonine phosphorylation. Northern analysis of PC12W mRNA with an AT1 receptor gene probe failed to produce an RNA:DNA hybrid at low stringency. These data indicate that PC12W cells express a homogeneous population of AT2 binding sites which differ significantly from AT1 receptors in signal transduction and molecular structure. AT2 sites may act via potentially novel, biochemical pathways or, alternatively, be vestigial receptors.
AB - The binding sites and biochemical effects of angiotensin (A) II were investigated in rat pheochromocytoma (PC12W) cells. Sarcosine1, [125I]-tyrosine4, isoleucine8-AII ([125I]-SI-AII) bound to a saturable population of sites on membranes with an equilibrium dissociation constant (Kd) of 0.4 nM and a binding site maximum of 254 fmol/mg protein. Competitive displacement of [125I]-SI-AII by agonists and antagonists elucidated a rank order of potency of AIII ≥ AII > PD 123177 > AI > [des-Phe]AII [AII(1-7)] ≫ DuP 753. The stable guanine nucleotide analog 5′-guanylyl imidodiphosphate did not alter the binding affinity or slope of the inhibition curves for AI, AII, AIII, or AII(1-7). Treatment of PC12W cells with AII or AIII did not affect the free intracellular calcium concentration, phosphoinositide metabolism, arachidonate release, cyclic GMP, or cyclic AMP concentrations. [125I]-AII binding sites remained on the cell surface and were not internalized after 2 h at 37°C. Angiotensin II did not stimulate tyrosine, serine, or threonine phosphorylation. Northern analysis of PC12W mRNA with an AT1 receptor gene probe failed to produce an RNA:DNA hybrid at low stringency. These data indicate that PC12W cells express a homogeneous population of AT2 binding sites which differ significantly from AT1 receptors in signal transduction and molecular structure. AT2 sites may act via potentially novel, biochemical pathways or, alternatively, be vestigial receptors.
KW - AT sites
KW - Angiotensin II
KW - Radioligand binding
KW - Signal transduction
UR - http://www.scopus.com/inward/record.url?scp=0026683963&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026683963&partnerID=8YFLogxK
U2 - 10.1016/0196-9781(92)90081-D
DO - 10.1016/0196-9781(92)90081-D
M3 - Article
C2 - 1326103
AN - SCOPUS:0026683963
VL - 13
SP - 499
EP - 508
JO - Peptides
JF - Peptides
SN - 0196-9781
IS - 3
ER -